Literature DB >> 19819199

Benchmarking biology research organizations using a new, dedicated tool.

Willem H van Harten1, Leonard van Bokhorst, Henri G A M van Luenen.   

Abstract

International competition forces fundamental research organizations to assess their relative performance. We present a benchmark tool for scientific research organizations where, contrary to existing models, the group leader is placed in a central position within the organization. We used it in a pilot benchmark study involving six research institutions. Our study shows that data collection and data comparison based on this new tool can be achieved. It proved possible to compare relative performance and organizational characteristics and to generate suggestions for improvement for most participants. However, strict definitions of the parameters used for the benchmark and a thorough insight into the organization of each of the benchmark partners is required to produce comparable data and draw firm conclusions.

Entities:  

Mesh:

Year:  2009        PMID: 19819199      PMCID: PMC5527963          DOI: 10.1016/j.molonc.2009.09.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  2 in total

1.  The balanced scorecard--measures that drive performance.

Authors:  R S Kaplan; D P Norton
Journal:  Harv Bus Rev       Date:  1992 Jan-Feb

2.  Benchmarking biology research organizations using a new, dedicated tool.

Authors:  Willem H van Harten; Leonard van Bokhorst; Henri G A M van Luenen
Journal:  Mol Oncol       Date:  2009-09-18       Impact factor: 6.603

  2 in total
  2 in total

1.  Benchmarking biology research organizations using a new, dedicated tool.

Authors:  Willem H van Harten; Leonard van Bokhorst; Henri G A M van Luenen
Journal:  Mol Oncol       Date:  2009-09-18       Impact factor: 6.603

2.  International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres.

Authors:  Wineke A M van Lent; Relinde D de Beer; Wim H van Harten
Journal:  BMC Health Serv Res       Date:  2010-08-31       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.